Tumor-suppressing protein may be novel target in PAH therapy

In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH).
Source: EurekaAlert, https://www.eurekalert.org